Anne Letsch

3.5k total citations
88 papers, 2.2k citations indexed

About

Anne Letsch is a scholar working on Oncology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anne Letsch has authored 88 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 41 papers in Immunology and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anne Letsch's work include Immunotherapy and Immune Responses (33 papers), Palliative Care and End-of-Life Issues (20 papers) and T-cell and B-cell Immunology (19 papers). Anne Letsch is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Palliative Care and End-of-Life Issues (20 papers) and T-cell and B-cell Immunology (19 papers). Anne Letsch collaborates with scholars based in Germany, United States and Switzerland. Anne Letsch's co-authors include Carmen Scheibenbogen, Ulrich Keilholz, Eckhard Thiel, Dirk Nagorsen, Alexander Schmittel, Anne Marie Asemissen, Sandra Bauer, Antonia Busse, Francesco M. Marincola and Lutz Uharek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Anne Letsch

82 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Letsch Germany 23 1.3k 1.1k 647 245 242 88 2.2k
Dorothee Wernet Germany 26 1.1k 0.9× 546 0.5× 717 1.1× 252 1.0× 274 1.1× 64 2.2k
Jeffrey VanDeusen United States 19 1.4k 1.1× 632 0.6× 472 0.7× 209 0.9× 62 0.3× 44 2.3k
Phuong Nguyen United States 30 1.6k 1.3× 912 0.8× 523 0.8× 330 1.3× 77 0.3× 88 2.7k
Mary Peterson United States 21 1.8k 1.4× 476 0.4× 422 0.7× 163 0.7× 120 0.5× 51 2.4k
David Vermijlen Belgium 28 2.2k 1.8× 939 0.9× 356 0.6× 133 0.5× 83 0.3× 63 2.9k
Fuat Oduncu Germany 23 430 0.3× 643 0.6× 576 0.9× 230 0.9× 160 0.7× 74 1.5k
D. Chang United States 24 1.0k 0.8× 730 0.7× 528 0.8× 308 1.3× 49 0.2× 128 2.7k
Yuri Fedoriw United States 23 331 0.3× 640 0.6× 555 0.9× 300 1.2× 244 1.0× 110 1.9k
Courtney Beers United States 20 1.8k 1.4× 727 0.7× 517 0.8× 143 0.6× 83 0.3× 31 2.8k
Kevin Thia Australia 17 1.4k 1.1× 625 0.6× 465 0.7× 282 1.2× 89 0.4× 26 1.9k

Countries citing papers authored by Anne Letsch

Since Specialization
Citations

This map shows the geographic impact of Anne Letsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Letsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Letsch more than expected).

Fields of papers citing papers by Anne Letsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Letsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Letsch. The network helps show where Anne Letsch may publish in the future.

Co-authorship network of co-authors of Anne Letsch

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Letsch. A scholar is included among the top collaborators of Anne Letsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Letsch. Anne Letsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Frick, Johann, et al.. (2024). The effect of social care nurses on health related quality of life in patients with advanced cancer: A non-randomized, multicenter, controlled trial. Quality of Life Research. 33(12). 3387–3399. 1 indexed citations
6.
Krug, Utz, et al.. (2023). Symptom- und Belastungsscreening bei Patienten mit inkurabler Erkrankung. 29(3). 237–245. 2 indexed citations
7.
Alt‐Epping, Bernd, Anne Letsch, Peter Thuss‐Patience, et al.. (2022). Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial. ESMO Open. 7(6). 100623–100623. 9 indexed citations
8.
Garrido, Pilar, Alex A. Adjei, Jyoti Bajpai, et al.. (2021). Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey. ESMO Open. 6(3). 100131–100131. 15 indexed citations
9.
Kühne, Franziska, et al.. (2021). Prognostic Awareness in Advanced Disease: A Review Update and Concept Analysis. Frontiers in Psychology. 12. 629050–629050. 11 indexed citations
10.
Quass, Petra, Annika Nelde, Heiko Schuster, et al.. (2020). Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo. Cancer Immunology Immunotherapy. 69(7). 1217–1227. 5 indexed citations
11.
Letsch, Anne, C. Benedikt Westphalen, Ulrich Keilholz, et al.. (2020). Information, communication, and cancer patients’ trust in the physician: what challenges do we have to face in an era of precision cancer medicine?. Supportive Care in Cancer. 29(4). 2171–2178. 17 indexed citations
12.
Wagner, Dorothea, Sabine Oertelt‐Prigione, Alex A. Adjei, et al.. (2019). Gender medicine and oncology: report and consensus of an ESMO workshop. Annals of Oncology. 30(12). 1914–1924. 132 indexed citations
13.
Welters, Marij J.P., Cécile Gouttefangeas, Tamara H. Ramwadhdoebé, et al.. (2012). Harmonization of the intracellular cytokine staining assay. Cancer Immunology Immunotherapy. 61(7). 967–978. 32 indexed citations
14.
Akkooi, Alexander C. J. van, et al.. (2011). Clinically misinterpreted melanoma metastases can correctly be diagnosed by ultrasound-guided fine needle aspiration cytology. European Journal of Dermatology. 21(2). 238–241. 4 indexed citations
15.
Busse, Antonia, Anne Letsch, Carmen Scheibenbogen, et al.. (2010). Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination. Journal of Translational Medicine. 8(1). 5–5. 11 indexed citations
16.
Na, Il‐Kang, Ulrich Keilholz, Anne Letsch, et al.. (2006). Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells. Cancer Immunology Immunotherapy. 56(3). 391–396. 8 indexed citations
17.
Letsch, Anne, Ulrich Keilholz, Florian Kern, et al.. (2006). Specific Central Memory T Cells in the Bone Marrow of Patients Immunized Against Tyrosinase Peptides. Journal of Immunotherapy. 29(2). 201–207. 10 indexed citations
18.
Nagorsen, Dirk, Carmen Scheibenbogen, Anne Letsch, et al.. (2005). T cell responses against tumor associated antigens and prognosis in colorectal cancer patients. Journal of Translational Medicine. 3(1). 3–3. 22 indexed citations
19.
Letsch, Anne, Ulrich Keilholz, Dirk Schadendorf, et al.. (2004). Functional CCR9 Expression Is Associated with Small Intestinal Metastasis. Journal of Investigative Dermatology. 122(3). 685–690. 70 indexed citations
20.
Asemissen, Anne Marie, Dirk Nagorsen, Ulrich Keilholz, et al.. (2001). Flow cytometric determination of intracellular or secreted IFNγ for the quantification of antigen reactive T cells. Journal of Immunological Methods. 251(1-2). 101–108. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026